Identification and characterization of new impurity in didanosine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 3, 2007, Pages 516-520

  Rao, D V N Srinivasa ^a   Srinivas, N ^a   Bharathi, Ch ^a   Prasad, Ch S ^a   Dandala, Ramesh ^a   Naidu, A ^b  

^a Aurobindo Pharma Research Centre   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Characterization; Didanosine; Impurities; Isolation; Preparative HPLC

Indexed keywords

0 (2,3,5 TRIDEOXY BETA D GLYCERO PENTOFURANOSYL) 9H PURIN 6 ONE (2',3',5' TRIDEOXYINOSINE); DIDANOSINE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG IMPURITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIDANOSINE; DRUG CONTAMINATION; INOSINE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TANDEM MASS SPECTROMETRY;

EID: 35349015781     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.05.034     Document Type: Article

References (11)

1. de Clercq E.J. Clin. Virol. 30 (2004) 115-133
2. de Clercq E. Int. J. Biochem. Cell Bio. 36 (2004) 1800-1822
3. Nassar M.N., Chen T., Reff M.J., and Agharkar N. Anal. Profiles Drug Subst. Excipients 22 (1993) 185-227
4. Anderson B.D., Wygant M.B., Xiang T.X., Waugh W.A., and Stella V.J. Int. J. Chromatogr. 45 (1998) 27
5. Ray G., and Murrill E. Anal. Lett. 20 (1987) 1815
6. Carpen M.E., Poplack D.G., Pizzo P.A., and Balir F.M. J. Chromatogr. 526 (1990) 69
7. Knupp C.A., Stanto F.A., Papp E.A., and Barbhaiya R. J. Chromatogr 533 (1990) 282
8. Yarchoan R., Mitsuya H., Thomas R.V., Pluda J.M., Hartman N.R., Perno C., Marezk K.S., Allain J., Johns D.G., and Broder S. Science 245 (1989) 412
9. de Olivera A.M.C., Lowen T.C.R., Cabral L.M., dos Santos E.M., Rodrigues C.R., Castro H.C., and dos Santos T.C. J. Pharm. Biomed. Anal. 38 (2005) 751-756
10. European Pharmacopoeia, 5.2, 2005, pp. 3193-3194, http://www.edqm.eu.
11. ICH Guideline Q3A (R), Impurities in New Drug Substances, 7 February 2002, http://www.ich.org.